NumFin

Insmed Incorporated

Symbol: INSM

NASDAQ

26.58

USD

Market price today

  • -5.0132

    P/E Ratio

  • 0.5125

    PEG Ratio

  • 3.95B

    MRK Cap

  • 0.00%

    DIV Yield

Insmed Incorporated (INSM) Financial Statements

Download
AnnualQuarterly
LinearLog
On the chart you can see the default numbers in dynamics for Insmed Incorporated (INSM). Companys revenue shows the average of 44.723 M which is 1.290 % gowth. The average gross profit for the whole period is 31.714 M which is 1.228 %. The average gross profit ratio is 0.509 %. The net income growth for the company last year performance is 0.557 % which equals -0.548 % % on average for the whole company history.,

AnnualQuarterly
10Y20Y30Y40Y

Balance Sheet

Diving into the fiscal trajectory of Insmed Incorporated, we observe an average asset growth. This rate, interestingly, stands at , reflecting both the company's highs and lows. When compared quarter-over-quarter, this figure adjusts to 0. A look back at the past year reveals a total asset change of -0.197. In the realm of current assets, INSM clocks in at 929.063 in the reporting currency. A significant portion of these assets, precisely 780.447, is held in cash and short-term investments. This segment shows a change of -0.320% when juxtaposed with last year's data. Long-term investments of the company, while not its focus, stand at 6, if any, in the reporting currency. This indicates a difference of 0.000% from the last reporting period, reflecting the company's strategic shifts. The debt profile of the company shows a total long-term debt of 1193.352 in the reporting currency. This figure signifies a year_over_year change of 0.022%. Shareholder value, as depicted by the total shareholder equity, is valued at -331.923 in the reporting currency. The year over year change in this aspect is -4.774%. A deeper dive into the company's financials reveals additional details. The net receivables are valued at 41.189, with an inventory valuation of 83.25, and goodwill valued at 136.11, if any. The total intangible assets, if present, are valued at 63.7. Account payables and short-term debt are 65.39 and 10.64, respectively. The total debt is 1203.99, with a net debt of 721.62. Other current liabilities amount to 214.99, adding to the total liabilities of 1661.76. Lastly, the referred stock is valued at 0, if it exists.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

balance-sheet.row.cash-and-short-term-investments

3482.85780.41148.3716.8
532.8
487.4
495.1
381.2
162.6
282.9
159.2
113.9
92.9
76.3
108
122.2
2.4
16.5
24.1
18.8
9.2
29.5
27.3
51.3
83.1
4.6

balance-sheet.row.short-term-investments

931.57298.174.20
0
0
0
0
0
0
0
0
2.2
61.4
97.3
109.4
0.3
0
0
0
0
0
0
0
11.5
4.3

balance-sheet.row.net-receivables

138.2441.229.724.4
16.6
19.2
5.5
0
0
0
0
0
0
0.8
0.5
2.3
0.1
0.3
0.2
0
0
0
0.2
3.5
0
0

balance-sheet.row.inventory

309.8483.269.967
49.6
28.3
7
0
0
0
0
0
0
0
0
0
0
0
0.6
0
0
0
0
0
0
0

balance-sheet.row.other-current-assets

106.224.225.528.9
24
20.2
11.3
8.3
5.8
5.2
5.5
2.3
0.6
0.4
0.3
0.2
0.1
0.2
0.1
0.1
0.2
0.2
0.6
0.3
1.5
0

balance-sheet.row.total-current-assets

4037.13929.11273.4837
622.9
555.2
518.9
389.4
168.4
288.1
164.7
116.2
93.6
77.4
108.8
124.6
2.6
17
25.4
19.2
9.7
29.8
28.2
55
84.6
4.7

balance-sheet.row.property-plant-equipment-net

413.78104.4102.195.5
97.2
113.1
22.6
12.4
10
8.1
7.5
1.8
1.7
1.9
1.1
0
0
0
0
0
0
0.1
0.2
1.2
1.6
0.2

balance-sheet.row.goodwill

544.44136.1136.1136.1
0
0
0
0
0
0
0
0
0
0
6.3
0
0
0
0
0
0
0
0
15.4
0
0

balance-sheet.row.intangible-assets

262.3963.768.873.8
49.3
53.7
58.7
58.2
58.2
58.2
58.2
58.2
58.2
58.2
0
0
0
0
0
0
0
0
0
0
16.2
0

balance-sheet.row.goodwill-and-intangible-assets

806.83199.8204.9209.9
49.3
53.7
58.7
58.2
58.2
58.2
58.2
58.2
58.2
58.2
6.3
0
0
0
0
0
0
0
0
15.4
16.2
0

balance-sheet.row.long-term-investments

166050
0
0
0
0
0
0
0
0
0
2.1
2.2
2.1
0
0.3
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

-16-600
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

353.8396.676.151
26.8
20.3
4.3
2
1.3
2.1
0.4
0.3
0.1
0.2
77.9
0
2.2
2.3
2.9
3.6
3.3
0
0
0
0.3
0.4

balance-sheet.row.total-non-current-assets

1574.44400.8383.1406.5
173.3
187.1
85.6
72.6
69.5
68.4
66.2
60.3
60
62.4
87.5
2.1
2.2
2.5
2.9
3.7
3.3
0.1
0.2
16.6
18.1
0.6

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

5611.571329.81656.41243.5
796.2
742.3
604.6
462
238
356.6
230.9
176.5
153.6
139.8
196.3
126.7
4.8
19.5
28.3
22.9
13
29.8
28.3
71.6
102.7
5.3

balance-sheet.row.account-payables

243.1465.450.535.8
42.9
13.2
17.7
14.7
10.4
7.5
9.2
5.9
7.1
2.3
1.4
0.3
1.3
0.9
7.2
1
2.6
0.7
0.9
4.4
3.4
0.7

balance-sheet.row.short-term-debt

35.1710.68.110.1
12.6
12.3
0
0
0
3.1
0
3.3
3.1
0.1
0.1
0.2
1.6
1.3
0
0
0
0
2.3
5
0
0

balance-sheet.row.tax-payables

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

4738.391193.41169.7602.1
392.3
384.8
316.6
55.6
54.8
22
24.9
16.3
16.3
1.1
0.1
0
0.5
2.1
3.2
6.4
0
0
0
0
0
0

Deferred Revenue Non Current

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1.7
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

722.76215131.789.2
63.4
0.3
62
30
17.6
0.7
10.4
7.2
5.6
2
1.3
1.7
1.5
1.3
2.5
3.9
2.4
2.3
0.4
0.7
0.7
0.1

balance-sheet.row.total-non-current-liabilities

5618.651436.11378.2697.9
401.5
395.4
316.6
56.3
55.5
22.6
25
16.7
16.9
1.1
0.1
0
2.7
4.3
4.8
7.5
0.7
0.6
1
1.7
1.8
0

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

198.7348.752.645.7
48.5
61.1
0
0
0
0
0
0.1
0.2
1.2
0.2
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

6433.241661.81568.5833
520.3
480.6
396.3
101
83.5
44.9
44.6
33.2
32.7
5.6
3.4
2.8
7.6
8
14.5
12.3
5.8
3.6
4.9
11.9
5.9
0.8

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0.9
0
0
0
0
0
0
0
0
0
0
0.1

balance-sheet.row.common-stock

5.71.51.41.2
1
0.9
0.8
0.8
0.6
0.6
0.5
0.4
0.3
0.2
1.6
1.3
1.2
1.2
1
0.7
0.4
0.4
0.3
0.3
0.3
0

balance-sheet.row.retained-earnings

-12663.72-3446.1-2696.6-2265.2
-1830.6
-1536.5
-1282.2
-957.9
-765.2
-589
-470.8
-391.6
-335.5
-294.2
-234.5
-228.1
-346.4
-330.8
-310.8
-254.7
-213.7
-186.5
-176.2
-139.8
-102.6
-22.8

balance-sheet.row.accumulated-other-comprehensive-income-loss

-2.99-0.70.81
0.2
0
0
0
-0.1
-5.3
-3.3
-3.6
0
0.5
1
0.4
0
-0.2
-0.5
-0.5
-0.5
-0.5
-0.4
-1.2
0.2
-0.1

balance-sheet.row.other-total-stockholders-equity

11839.333113.52782.42673.6
2105.3
1797.3
1489.7
1318.2
919.2
905.3
659.8
538.1
456.1
427.7
423.9
350.2
342.4
341.3
324.2
265
221
212.8
199.7
200.3
198.9
27.2

balance-sheet.row.total-stockholders-equity

-821.68-331.988410.5
275.9
261.7
208.3
361.1
154.5
311.7
186.2
143.3
120.9
134.3
192.8
123.9
-2.8
11.5
13.9
10.5
7.2
26.2
23.4
59.7
96.8
4.5

balance-sheet.row.total-liabilities-and-stockholders-equity

5611.571329.81656.41243.5
796.2
742.3
604.6
462
238
356.6
230.9
176.5
153.6
139.8
196.3
126.7
4.8
19.5
28.3
22.9
13
29.8
28.3
71.6
102.7
5.3

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

-821.68-331.988410.5
275.9
261.7
208.3
361.1
154.5
311.7
186.2
143.3
120.9
134.3
192.8
123.9
-2.8
11.5
13.9
10.5
7.2
26.2
23.4
59.7
96.8
4.5

balance-sheet.row.total-liabilities-and-total-equity

5611.57---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

931.57298.174.250
0
0
0
0
0
0
0
0
2.2
63.5
99.5
111.5
0.3
0.3
0
0
0
0
0
0
11.5
4.3

balance-sheet.row.total-debt

4773.5612041177.9612.3
404.8
397
316.6
55.6
54.8
25.1
24.9
19.7
19.4
1.2
0.2
0.2
2.1
3.4
3.2
6.4
0
0
0
0
0
0

balance-sheet.row.net-debt

2222.28721.6103.8-104.5
-127.9
-90.4
-178.5
-325.6
-107.8
-257.7
-134.4
-94.2
-71.4
-13.6
-10.6
-12.5
0
-13.1
-21
-12.4
-9.2
-29.5
-27.3
-51.3
-71.6
-0.3

Cash Flow Statement

The financial landscape of Insmed Incorporated has seen a noteworthy change in free cash flow over the last period, exhibiting a shift of -0.339. The company recently extended its share capital by issuing 152.47, marking a difference of 9.064 compared to the previous year. Interestingly, a portion of the company's stock, specifically 0, was bought back by the company itself. This action resulted in a change of 0.000 from the previous year. Meanwhile, the company's account payables are currently standing at 15.15 in the reporting currency. The company's investing activities resulted in net cash usage, amounting to -223604000.000 in the reporting currency. This is a shift of 5.466 from the previous year. In the same period, the company recorded 10.58, 0, and -1.22, which are significant to understanding the company's investment and repayment strategies. The company's financing activities led to a net cash usage of 0.000, with a year over year difference of 0.000. Furthermore, the company allocated 0 for dividend payouts to its shareholders. At the same time, it engaged in other financial maneuvers, referred to as 17.18, which also significantly impacted its cash flow during this period. These components, taken together, paint a comprehensive picture of the company's financial status and strategic approach towards cash flow management.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

cash-flows.row.net-income

-749.57-749.6-481.5-434.7
-294.1
-254.3
-324.3
-192.6
-176.3
-118.2
-79.2
-56.1
-41.4
-59.7
-6.4
118.3
-15.7
-20
-56.1
-40.9
-27.2
-10.3
-36.4
-37.2
-79.9
-7.8

cash-flows.row.depreciation-and-amortization

10.5810.610.314.2
14.2
10.2
4.8
2.9
2.4
2
1.1
0.7
0.6
0.3
0.1
0.7
1
0.4
3.4
12.9
0
0.1
0.3
1.5
0.8
0.1

cash-flows.row.deferred-income-tax

077017.7
0
0
2.2
0
0
0
0
0
-0.8
0
0
0
0.5
-0.5
-0.9
0
0
0
-0.1
-0.1
0
0

cash-flows.row.stock-based-compensation

74.7874.857.746
36.2
27
26.2
18.1
18
15.6
11.3
8.7
3
1.6
0.4
2.5
0.8
0.5
0.9
0
0
0
0.1
0.1
0
0

cash-flows.row.change-in-working-capital

-39.22-39.26.6-58.6
-3
-63
15.7
11.3
8.6
-0.6
1.8
-0.4
7.4
1.5
-1.7
-5.1
1.1
-6.3
4.6
0.2
2.2
-0.7
-3.5
4
2.1
0.2

cash-flows.row.account-receivables

-11.96-12-6.4-8.1
2.7
-13.7
-5.5
0
0
0
0
0
0.8
-0.3
0
-0.1
0.1
0
-0.2
0
0
0
0
0
0
0

cash-flows.row.inventory

-13.61-13.6-1.7-17.5
-21.2
-21.3
-7
0
0
0
0
0
0.5
1.7
-104.4
-1.8
0.2
0.6
-0.6
0
0
0
0
0
0
0

cash-flows.row.account-payables

17.4415.250-7.6
29.8
-5
3.9
3.6
2.8
-1.8
3.3
-1.1
4.7
0.9
-2.8
-1
0.4
-6.3
6.2
-1.7
2
-3.5
1.8
1.8
0
0

cash-flows.row.other-working-capital

-10.34-28.8-35.3-25.4
-14.3
-23
24.4
7.7
5.9
1.2
-1.5
0.7
1.4
-0.7
105.5
-2.3
0.4
-0.5
-0.8
1.9
0.3
2.8
-5.4
2.2
2.1
0.2

cash-flows.row.other-non-cash-items

167.1890.26.552
27.4
29.5
17.3
0.8
0.5
0.5
0.5
0.5
0.3
26
0
-127.5
0.1
0.6
6
0
0
0.1
15.5
-0.1
55.6
0.3

cash-flows.row.net-cash-provided-by-operating-activities

-536.25000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

-13.29-13.3-9.9-7.3
-6.8
-42.3
-14.8
-3
-4.2
-3.5
-5.4
-0.8
-0.3
-1
6.7
0
0
0
-5
0
0
0
-0.3
-0.3
-1.3
-0.1

cash-flows.row.acquisitions-net

-103.424.7-6.7
0
0
0
0
0
0
0
0
0
0
-6.7
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

-588.73-588.7-99.7-50.3
0
0
0
0
0
0
0
0
-19.7
-1.2
-102.5
-108.7
0
-0.5
0
0
0
0
0
0
-19.2
-4.3

cash-flows.row.sales-maturities-of-investments

3753757557
0
0
0
0
0
0
0
2.2
81.5
36.5
115.2
0
12.7
9.1
0
0
0
0
-0.2
11.5
12.3
0

cash-flows.row.other-investing-activites

-210.850-24.7-57
0
0
0
0
0
0
0
0
0
0
-6.7
127.5
0
0
0
0
0
0
11.7
0
3.6
0

cash-flows.row.net-cash-used-for-investing-activites

-223.6-223.6-34.6-64.3
-6.8
-42.3
-14.8
-3
-4.2
-3.5
-5.3
1.3
61.5
34.4
6
18.7
12.7
8.6
-5
0
0
0
11.2
11.2
-4.6
-4.4

cash-flows.row.debt-repayment

-3.55-1.2-482.2-225
-0.9
0
-57.8
0
0
0
-0.1
-0.1
-0.1
-0.1
-0.2
-1.2
-2.2
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

163.24152.5292.2269.9
245.9
261.1
0
377.7
0
222.9
109
67
25.7
0
0
0.6
0.1
17.1
52.2
4.6
8.2
13
0.2
0.2
97.3
0.3

cash-flows.row.common-stock-repurchased

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.dividends-paid

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

54.3317.2983.3567.7
26.1
24.2
444.6
3.4
30.7
4.9
6.1
1.5
19.9
0
0
3.5
0
1
0.3
32.8
-3.6
0
0
0
0.1
0

cash-flows.row.net-cash-used-provided-by-financing-activities

168.44168.4793.3612.5
271
285.3
386.7
381.1
30.7
227.8
115.1
68.4
45.4
-0.1
-0.2
2.9
-2.1
18.1
52.5
37.4
4.6
13
0.2
0.2
97.4
0.3

cash-flows.row.effect-of-forex-changes-on-cash

-0.25-0.3-1-0.9
0.5
0
0
0.1
-0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
-11.2
0
0
0

cash-flows.row.net-change-in-cash

-591.66-591.7357.3184
45.3
-7.6
113.9
218.6
-120.3
123.7
45.3
23.1
75.9
4.1
-2
10.6
-1.4
1.4
5.3
9.6
-20.3
2.2
-23.9
-20.4
71.3
-11.4

cash-flows.row.cash-at-end-of-period

2551.28482.41074716.8
532.8
487.4
495.1
381.2
162.6
282.9
159.2
113.9
90.8
14.8
10.7
12.7
2.1
3.6
24.1
18.8
9.2
29.5
27.3
51.3
71.6
0.3

cash-flows.row.cash-at-beginning-of-period

3142.941074716.8532.8
487.4
495.1
381.2
162.6
282.9
159.2
113.9
90.8
14.8
10.7
12.7
2.1
3.6
2.1
18.8
9.2
29.5
27.3
51.3
71.6
0.3
11.7

cash-flows.row.operating-cash-flow

-536.25-536.2-400.4-363.3
-219.3
-250.6
-258
-159.6
-146.7
-100.7
-64.4
-46.7
-31
-30.2
-7.7
-11
-12
-25.3
-42.2
-27.8
-24.9
-10.8
-24.1
-31.8
-21.4
-7.2

cash-flows.row.capital-expenditure

-13.29-13.3-9.9-7.3
-6.8
-42.3
-14.8
-3
-4.2
-3.5
-5.4
-0.8
-0.3
-1
6.7
0
0
0
-5
0
0
0
-0.3
-0.3
-1.3
-0.1

cash-flows.row.free-cash-flow

-549.53-549.5-410.3-370.6
-226.2
-292.9
-272.8
-162.6
-150.9
-104.2
-69.8
-47.5
-31.3
-31.2
-1
-11
-12
-25.3
-47.2
-27.8
-24.9
-10.8
-24.3
-32
-22.7
-7.3

Income Statement Row

Insmed Incorporated's revenue saw a change of 0.244% compared with the previous period. The gross profit of INSM is reported to be 239.63. The company's operating expenses are 920.56, showing a change of 37.736% from the last year. The expenses for depreciation and amortization are 10.58, which is a -0.469% change from the last accounting period. Operating expenses are reported to be 920.56, which shows a 37.736% year-over-year change. Selling and marketing expenses are 0, which is a 0.000% change compared to the previous year. The EBITDA based on the recent numbers is 0, representing a -0.484% year-over-year growth. The operating income is -709.63, which shows a 0.484% change when compared to the previous year. The change in the net income is 0.557%. The net income for the last year was -749.57.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999

income-statement-row.row.total-revenue

305.21305.2245.4188.5
164.4
136.5
9.8
0
0
0
11.5
11.5
0
4.4
6.9
10.4
11.7
7.5
1
0.1
0.1
0.1
2
0.3
0.1
0.7

income-statement-row.row.cost-of-revenue

65.5765.655.144.2
39.9
24.2
2.4
2.9
2.4
2
33.5
29.6
21.4
0
0
0
0
0.6
1.5
0
0
0
0
0
0
-0.1

income-statement-row.row.gross-profit

239.63239.6190.2144.3
124.5
112.3
7.4
-2.9
-2.4
-2
-22
-18.1
-21.4
4.4
6.9
10.4
11.7
7
-0.5
0.1
0.1
0.1
2
0.3
0.1
0.7

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

571.01---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

344.5---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

3.231.95.15.1
5
5
0.6
0.3
0.1
0
0.1
0
0
12.2
10.3
9.8
5.1
8.5
32.8
5.7
4.2
3.6
18.4
0.1
0
2.5

income-statement-row.row.operating-expenses

920.56920.6668.4512.1
389.8
347.5
314.8
188.9
173.4
117.5
87.4
66.5
42.4
40.1
15
19
26.1
27.4
53.9
27.6
27.6
10.7
36.4
40.5
31.2
8.9

income-statement-row.row.cost-and-expenses

986.14986.1723.5556.2
429.6
371.7
317.2
188.9
173.4
117.5
87.4
66.5
42.4
40.1
15
19
26.1
28
55.4
27.6
27.6
10.7
36.4
40.5
31.2
8.8

income-statement-row.row.interest-income

1.881.911.10.2
1.7
9.9
0
0
0
0
0
0
0
0
1.8
0
0.5
1.2
1.9
0.8
0
0
0.6
0
0
0

income-statement-row.row.interest-expense

77.9176.326.440.5
29.6
27.7
25.5
5.9
3.5
2.9
2.4
2.4
0.8
0
0.1
0.8
1.3
-0.7
-3.7
-14.2
0
0
0
0
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

-4.3915.6-2-68.7
-27.5
-18.3
8.7
1.9
0.7
0.2
0.2
0.1
1.8
-23.9
1.8
128.3
-0.5
0.5
-7.1
-13.5
-9
-0.1
-17.9
3
-50.4
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

3.231.95.15.1
5
5
0.6
0.3
0.1
0
0.1
0
0
12.2
10.3
9.8
5.1
8.5
32.8
5.7
4.2
3.6
18.4
0.1
0
2.5

income-statement-row.row.total-operating-expenses

-4.3915.6-2-68.7
-27.5
-18.3
8.7
1.9
0.7
0.2
0.2
0.1
1.8
-23.9
1.8
128.3
-0.5
0.5
-7.1
-13.5
-9
-0.1
-17.9
3
-50.4
0

income-statement-row.row.interest-expense

77.9176.326.440.5
29.6
27.7
25.5
5.9
3.5
2.9
2.4
2.4
0.8
0
0.1
0.8
1.3
-0.7
-3.7
-14.2
0
0
0
0
0
0

income-statement-row.row.depreciation-and-amortization

18.7210.619.9-5.6
5.4
4.5
1.2
2.9
2.4
2
1.1
0.7
0.6
0.3
0.1
0.7
1
0.4
3.4
12.9
0
0.1
0.3
1.5
0.8
0.1

income-statement-row.row.ebitda-caps

-664.03---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

-719.13-709.6-478.1-367.8
-265.2
-235.2
-307.3
-188.9
-173.4
-117.5
-87.4
-55
-42.4
-61.7
-8.1
-8.7
-14.4
-20.4
-54.4
-27.4
-27.4
-10.6
-37
-40.2
-81.5
-8.1

income-statement-row.row.income-before-tax

-747.01-747-480.2-436.4
-292.7
-253.6
-324.1
-192.9
-176.2
-120.2
-89.6
-57.3
-41.4
-59.7
-6.4
118.8
-15.7
-20
-56.1
-40.9
-36.4
-10.3
-36.4
-37.2
-79.7
0

income-statement-row.row.income-tax-expense

2.562.61.4-1.8
1.4
0.8
0.2
-0.3
0.1
-2
-10.4
-1.2
0.8
9.2
0.1
0.5
1.3
0
1.8
0
-9.2
-0.3
1.9
-74.3
0.2
-0.3

income-statement-row.row.net-income

-749.57-749.6-481.5-434.7
-294.1
-254.3
-324.3
-192.6
-176.3
-118.2
-79.2
-56.1
-41.4
-59.7
-6.4
118.3
-15.7
-20
-56.1
-40.9
-27.2
-10.3
-36.4
-37.2
-79.9
-7.8
Similar Stocks
You may also be interested in:
SRNE
Sorrento Therapeutics, Inc..
0.016 USD
NASDAQ
MRVI
Maravai LifeSciences Holdings, Inc..
9.01 USD
NASDAQ
CMRA
Comera Life Sciences Holdings, Inc..
0.0212 USD
NASDAQ
GUBRA.CO
Gubra A/S.
309 DKK
CPH
T5O.DE
CytoTools AG.
0.468 EUR
XETRA
6826.HK
Shanghai Haohai Biological Technology Co., Ltd..
42.4 HKD
HKSE
PPBT
Purple Biotech Ltd..
0.67 USD
NASDAQ

Frequently Asked Question

What is Insmed Incorporated (INSM) total assets?

Insmed Incorporated (INSM) total assets is 1329837000.000.

What is enterprise annual revenue?

The annual revenue is 162765000.000.

What is firm profit margin?

Firm profit margin is 0.785.

What is company free cash flow?

The free cash flow is -3.795.

What is enterprise net profit margin?

The net profit margin is -2.456.

What is firm total revenue?

The total revenue is -2.356.

What is Insmed Incorporated (INSM) net profit (net income)?

The net profit (net income) is -749567000.000.

What is firm total debt?

The total debt is 1203994000.000.

What is operating expences number?

The operating expences are 920564000.000.

What is company cash figure?

Enretprise cash is 482374000.000.